Companies: 10,795·Total market cap: $144.5T
Alignment Healthcare, Inc.

Alignment Healthcare, Inc.

ALHCNASDAQHealthcare● Active
$15.35
$-0.02(-0.13%)
Market Cap$3.2B
P/E Ratio
52W High$23.87
52W Low$11.625
Overview

Alignment Healthcare, Inc. (ALHC) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

alhc · stock forecast · 16 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 16 Wall Street analysts in the past 3 months

SellBuy

Buy

16 analysts

consensus

Rating Breakdown

Strong Buy
1
Buy
13
Hold
2
Sell
0
Strong Sell
0
Total: 16 · Buy rate: 87.5%

12-Month Price Target

High

$30.00

Consensus

$24.33

+57.8% upside

Low

$16.00

Median: $25 · Last Close: $15.42

The Alignment Healthcare, Inc. (ALHC) analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month ALHC price target is $24.33, representing +57.8% upside from the current price of $15.42.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $24 (57.8%)

Consensus Target

$24.33

57.8% upside

High Target

$30

94.6%

Low Target

$16

3.8%

Current Price

$15.42

as of today

Based on analyst price targets, the ALHC stock price prediction for the next 12 months ranges from $16 to $30. The consensus ALHC price forecast of $24.33 implies 57.8% upside from the current price of $15.42.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$14.655.00%

1-day model range: $14.52–$14.78. Peak: $14.78 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$21+39.3%
2028$27+72.1%
2029$30+96.4%
2030$33+113.1%
2031+123.9%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

29%7%64%
4Buy
1Neutral
9Sell
RSI (14)42.7Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ALHC · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$14.75BUY
MA 10$15.02BUY
MA 20$15.92SELL
MA 50$18.40SELL
MA 100$19.27SELL
MA 200$18.53SELL
Current $ALHC · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$15.07BUY
EMA 10$15.22BUY
EMA 20$16.02SELL
EMA 50$17.54SELL
EMA 100$18.28SELL
EMA 200$17.97SELL
Current $ALHC · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Barclays2026-05-26
Maintains
Equal WeightEqual Weight
UBS2026-05-01
Maintains
NeutralNeutral
Barclays2026-05-01
Maintains
Equal WeightEqual Weight
JP Morgan2026-02-05
Maintains
OverweightOverweight
TD Cowen2026-01-16
Maintains
BuyBuy
UBS2026-01-14
Maintains
NeutralNeutral
Piper Sandler2026-01-06
Maintains
OverweightOverweight
JP Morgan2025-12-17
Maintains
OverweightOverweight
JP Morgan2025-11-24
Upgrade ↑
NeutralOverweight
JP Morgan2025-11-05
Maintains
NeutralNeutral

Wall Street analysts have recently issued updated ratings on Alignment Healthcare, Inc. (ALHC) stock. Of the recent 83 rating actions, 8 were upgrades and 4 were downgrades. 16 analysts currently cover ALHC.

Analyst Recommendation Trends

Buy ratings00
Hold ratings13↑ +2
Sell ratings00

ALHC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$5.2B

↓ 35.4% YoY

Revenue Next Year

$6.5B

↑ 25.5% YoY

EPS This Year

$0.18

EPS Next Year

$0.42

↑ 130.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ALHC EPS of $0.18 for the current fiscal year, based on estimates from 6 analysts. The ALHC revenue forecast is $5.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ALHC stock forecast is supported by two independent data sources: analyst consensus ratings from 16 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ALHC price target is $24.33 (+57.8% upside), with an analyst consensus of Buy.

The ALHC short-term stock prediction for tomorrow is $14.65 (-5.00%). The ALHC stock price prediction for 2027 estimates an average of $21. The ALHC stock prediction for 2030 projects a range of $30–$36.

Alignment Healthcare, Inc. trades on NASDAQ under the ticker ALHC. The ALHC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 88% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ALHC forecast · 8 questions

According to 16 Wall Street analysts, the average 12-month ALHC price target is $24.33, with a high forecast of $30.00 and a low of $16.00. The median price target is shown in the chart above when available. This implies +57.8% potential upside from the current price of $15.42.

ALHC price targetWhat is ALHC price targetALHC analyst price targetALHC 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.